0000950170-24-011475.txt : 20240205 0000950170-24-011475.hdr.sgml : 20240205 20240205201612 ACCESSION NUMBER: 0000950170-24-011475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240205 DATE AS OF CHANGE: 20240205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PALEKAR ROHAN CENTRAL INDEX KEY: 0001423327 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 24597736 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, THIRD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0508 4 2024-02-01 0001785173 89bio, Inc. ETNB 0001423327 PALEKAR ROHAN C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 true true false false Chief Executive Officer false Common Stock 2024-02-01 4 A false 150000 0.00 A 498714 D Common Stock 2024-02-05 4 F false 5068 9.80 D 493646 D Stock Option (Right to Buy) 9.98 2024-02-01 4 A false 605000 0 A 2034-02-01 Common Stock 605000 605000 D Represents restricted stock units ("RSUs") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer. These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation. This option represents a right to purchase a total of 605,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer. /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar 2024-02-05